Previous 10 | Next 10 |
2024-05-10 02:08:25 ET Summary iShares MSCI Denmark ETF has $290M in assets and tracks the MSCI Denmark index. EDEN is heavily concentrated in the Health Care sector, with 42% of its assets allocated there. The fund has significant allocations in industrials and financials, an...
2024-05-09 13:22:28 ET More on Novo Nordisk The FTC Cracks Down On Novo Nordisk's Ozempic Novo Nordisk A/S 2024 Q1 - Results - Earnings Call Presentation Novo Nordisk A/S (NVO) Q1 2024 Earnings Call Transcript Catalent, Novo Nordisk receive FTC request for mo...
2024-05-09 09:45:00 ET Novo Nordisk (NYSE: NVO) has been a great investment over the past few years. Since the start of 2022, shares of the Danish healthcare giant have risen by 120%, far outstripping the S&P 500 's return of just 8%. The company is a big name in diabetes ca...
2024-05-07 14:04:24 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Amid a challenging market environment, one of your best bets could be to target biotech stocks to buy. Yes, the sector can be volatile because much hinges on underlying breakthroughs. Never...
2024-05-07 13:24:47 ET More on Fresenius Medical Care Broyhill - Fresenius Medical Care: Correctly Focused On Increasing Margins And Returns Fresenius Medical Care AG (FMS) Q4 2023 Earnings Call Transcript Fresenius Medical Care AG 2023 Q4 - Results - Earnings Call P...
2024-05-04 15:30:00 ET Read the full article on Seeking Alpha For further details see: Pharma R&D productivity seen improving for the first time in years - Deloitte
2024-05-04 09:13:02 ET Summary Amgen's shares surged after management's earnings call comments about the phase 2 trial of obesity candidate MariTide. These comments and previous phase 2 data point to the increasing possibility of Amgen becoming a real contender in the rapidly expa...
2024-05-03 13:45:54 ET Summary The FTC is investigating improper patent listings, including Novo Nordisk's Ozempic, which could impact shareholders. Novo Nordisk's GLP-1 agonists, including Ozempic, have become a significant part of the company's revenue. The scrutiny from the...
2024-05-03 10:28:54 ET More on Amgen Amgen, Inc. (AMGN) Q1 2024 Earnings Call Transcript Amgen Stock: Recent Weakness Is Not A Buying Opportunity Yet Amgen: I Prefer To Chase Value And Dividends Biggest stock movers today: WOW, AAPL, SQ, and more Amge...
2024-05-03 09:26:24 ET More on Catalent Catalent - Novo Holdings Merger: Attractive Spread Catalent gains after filing 10-Q FTC likely to look at Catalent alternatives in review of Novo deal - report Seeking Alpha’s Quant Rating on Catalent His...
News, Short Squeeze, Breakout and More Instantly...
2024-07-17 13:21:54 ET Shares of Swiss pharmaceuticals company Roche Holding (OTC: RHHBY) soared 7% through 11:55 a.m. ET Wednesday on positive data from phase 1 clinical trials of its new weight loss drug CT-996. But good news for Roche is bad news for the companies that no...
2024-07-14 05:20:00 ET Two pharma juggernauts, Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) , are picking up speed in their preparations for an epic battle to control the market for weight loss drugs. The prize for the victor will be a larger market share of what may b...
2024-07-13 17:52:00 ET Novo Nordisk (NYSE: NVO) is already a stock that's easy to justify buying. Between the incredible success of Ozempic, tons of demand for its weight loss medicine, and big investments in manufacturing as well as its pipeline, optimism about its future is practi...